| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |